Skip to main content
Addgene

We narrowed to 25,203 results for: LARS

Showing: 301 - 320 of 25203 results
  1. pTRE3G-WHG cGASdeltaN-HA

    Plasmid
    #186868
    Purpose
    Doxycycline-dependent expression of white-handed gibbon cGAS gene in mammalian cells by retroviral transduction
    Depositor
    Insert
    White-handed gibbon cGAS truncation mutant (193-557 a.a.) with C-terminal HA tag
    Use
    Retroviral
    Tags
    HA
    Expression
    Mutation
    N-terminal truncation
    Promoter
    TRE3G
    Available since
    Oct. 23, 2024
    Availability
    Academic Institutions and Nonprofits only
  2. C321

    Bacterial Strain
    #48999
    Purpose
    Recoded E. coli MG1655 strain with wt UAG termination function (RF1 is still present)
    Depositor
    Bacterial Resistance
    Ampicillin
    Species
    Escherichia coli
    Available since
    Oct. 24, 2013
    Availability
    Academic Institutions and Nonprofits only
  3. C321.ΔA.exp

    Bacterial Strain
    #49018
    Purpose
    This is C321.DA with mutS reverted and the lambda prophage removed; it exhibits lesser spontaneous mutagenesis and can be grown at 37 C
    Depositor
    Bacterial Resistance
    Bleocin (zeocin)
    Species
    Escherichia coli
    Available since
    Feb. 18, 2014
    Availability
    Academic Institutions and Nonprofits only
  4. pAAV-Ef1a-DIO eNpHR 3.0-EYFP (AAV5)

    Viral Prep
    #26966-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-Ef1a-DIO eNpHR 3.0-EYFP (#26966). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO eNpHR 3.0-EYFP plasmid DNA. EF1a-driven, cre-dependent eNpHR 3.0-EYFP for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Tags
    EYFP (Cre-dependent)
    Available since
    Feb. 14, 2018
    Availability
    Academic Institutions and Nonprofits only
  5. pAAV-Ef1a-DIO eNpHR 3.0-EYFP (AAV9)

    Viral Prep
    #26966-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-Ef1a-DIO eNpHR 3.0-EYFP (#26966). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO eNpHR 3.0-EYFP plasmid DNA. EF1a-driven, cre-dependent eNpHR 3.0-EYFP for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Tags
    EYFP (Cre-dependent)
    Available since
    April 6, 2018
    Availability
    Academic Institutions and Nonprofits only
Showing: 301 - 320 of 25203 results